New tricks.
The article discusses the use of interleukin-2 in the cancer drug development efforts of researcher Floyd Romesberg and colleagues in collaboration with biotechnology firm Synthorx. Topics explored include the use of semisynthetic cells by the researchers to expand the genetic code, the anti-tumour...
| Publicado en: | Economist Vol. 430; no. 9126; pp. 76 - 78 |
|---|---|
| Formato: | Artículo |
| Publicado: |
Economist Newspaper Limited
1/19/2019
|
| Materias: | |
| Acceso en línea: | Ver este registro en EBSCOhost |